Powis et al. uncovered that induced pluripotent stem cells (iPSC) from SMA patients that had been differentiated into motor neurons exhibited reduced UBA1 expression levels, indicating that UBA1 may represent a potential therapeutic target for SMA. This evidence concerns the gene UBA1 and proximal spinal muscular atrophy.